Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hope Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of life-saving medications for rare and underserved medical conditions. The company is primarily recognized for its FDA-approved treatments for acute cyanide poisoning, including Nithiodote and individual injections of sodium nitrite and sodium thiosulfate. Beyond toxicology, Hope Pharmaceuticals is actively investigating the use of sodium thiosulfate for the treatment of calciphylaxis, a rare and often fatal condition involving systemic calcification of small blood vessels. Based in Scottsdale, Arizona, the company maintains a focused portfolio of niche products that address critical unmet needs in emergency medicine and nephrology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hope Pharmacy.